PubMed

Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category.

Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM.

Metab Syndr Relat Disord. 2009 Nov 24. [Epub ahead of print]PMID: 19929597 [PubMed - as supplied by publisher]

CD11c Expression in Adipose Tissue and Blood and Its Role in Diet-Induced Obesity.

Wu H, Perrard XD, Wang Q, Perrard JL, Polsani VR, Jones PH, Smith CW, Ballantyne CM.

Arterioscler Thromb Vasc Biol. 2009 Nov 12. [Epub ahead of print]PMID: 19910635 [PubMed - as supplied by publisher]Related articles

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.

Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM Jr, Ballantyne CM, Marian AJ.

BMC Med Genet. 2009 Oct 30;10:111.PMID: 19878569 [PubMed - in process]Related articlesFree article

Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations.

North KE, Franceschini N, Avery CL, Baird L, Graff M, Leppert M, Chung JH, Zhang J, Hanis C, Boerwinkle E, Volcik KA, Grove ML, Mosley TH, Gu C, Heiss G, Pankow JS, Couper DJ, Ballantyne CM, Linda Kao WH, Weder AB, Cooper RS, Ehret GB, O'Connor AA, Chakravarti A, Hunt SC.

Acta Diabetol. 2009 Oct 24. [Epub ahead of print]PMID: 19855918 [PubMed - as supplied by publisher]Related articles

Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study.

Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM; for the Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation and Thrombosis Research Group.

Diabetes Care. 2009 Oct 19. [Epub ahead of print]PMID: 19841042 [PubMed - as supplied by publisher]Related articles

Statin-induced diabetes: will it change clinical practice?

Belalcazar LM, Raghavan VA, Ballantyne CM.

Diabetes Care. 2009 Oct;32(10):1941-3. No abstract available. PMID: 19794006 [PubMed - in process]Related articles

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA; American College of Cardiology Foundation; American Heart Association; American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease); American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; National Lipid Association; Preventive Cardiovascular Nurses Association.

J Am Coll Cardiol. 2009 Sep 29;54(14):1336-63. No abstract available. PMID: 19778678 [PubMed - indexed for MEDLINE]Related articles

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA; American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; Preventive Cardiovascular Nurses Association.

Circulation. 2009 Sep 29;120(13):e100-26. Epub 2009 Sep 21. No abstract available. PMID: 19770387 [PubMed - indexed for MEDLINE]Related articles

Advances in lipid testing and management in patients with diabetes mellitus.

Vasudevan MM, Ballantyne CM.

Endocr Pract. 2009 Sep-Oct;15(6):641-52.PMID: 19625239 [PubMed - in process]Related articles

Inflammation, adipose tissue, and T cells: what is the "straight skinny" on lean versus fat mice?

Wu H, Ballantyne CM.

Circ Res. 2009 Jul 17;105(2):e3-4; author reply e5. No abstract available. PMID: 19608985 [PubMed - indexed for MEDLINE]Related articles

Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study.

Shiffman D, Chasman DI, Ballantyne CM, Nambi V, Devlin JJ, Boerwinkle E.

Thromb Haemost. 2009 Jul;102(1):179-80. No abstract available. PMID: 19572086 [PubMed - indexed for MEDLINE]Related articles

Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).

Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM.

Am J Cardiol. 2009 Jun 15;103(12):1694-702.PMID: 19539078 [PubMed - indexed for MEDLINE]Related articles

Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD).

Nambi V, Kimball KT, Bray PF, Bergeron AL, Johnson SL, Morrisett JD, Chen C, Lin PH, Lumsden AB, Ballantyne CM, Dong JF.

Platelets. 2009 May;20(3):199-205.PMID: 19437338 [PubMed - indexed for MEDLINE]Related articles

Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.

Wu H, Gower RM, Wang H, Perrard XY, Ma R, Bullard DC, Burns AR, Paul A, Smith CW, Simon SI, Ballantyne CM.

Circulation. 2009 May 26;119(20):2708-17. Epub 2009 May 11.PMID: 19433759 [PubMed - indexed for MEDLINE]Related articles

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council.

Circulation. 2009 May 5;119(17):2408-16. Epub 2009 Apr 13. Erratum in: Circulation. 2009 Jun 30;119(25):e606. Hong, Yuling [added]. PMID: 19364974 [PubMed - indexed for MEDLINE]Related articles

Using the whole cohort in the analysis of case-cohort data.

Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M.

Am J Epidemiol. 2009 Jun 1;169(11):1398-405. Epub 2009 Apr 8.PMID: 19357328 [PubMed - indexed for MEDLINE]Related articles

Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study.

Monda KL, Ballantyne CM, North KE.

J Lipid Res. 2009 Aug;50(8):1685-91. Epub 2009 Apr 3.PMID: 19346332 [PubMed - indexed for MEDLINE]Related articles

Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.

Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, August PA, Kshirsagar AV.

Nephrol Dial Transplant. 2009 Aug;24(8):2452-7. Epub 2009 Mar 26.PMID: 19324913 [PubMed - indexed for MEDLINE]Related articles

Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events.

Frazier L, Vaughn WK, Willerson JT, Ballantyne CM, Boerwinkle E.

Biol Res Nurs. 2009 Oct;11(2):163-73. Epub 2009 Feb 26.PMID: 19251718 [PubMed - in process]Related articles

Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.

Goldberg AC, Bays HE, Ballantyne CM, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC.

Am J Cardiol. 2009 Feb 15;103(4):515-22. Epub 2008 Dec 26.PMID: 19195513 [PubMed - indexed for MEDLINE]Related articles

The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.

Chen SN, Ballantyne CM, Gotto AM Jr, Marian AJ.

BMC Cardiovasc Disord. 2009 Jan 27;9:3.PMID: 19173706 [PubMed - indexed for MEDLINE]Related articlesFree article

"Risky business": ten years is not a lifetime.

Nambi V, Ballantyne CM.

Circulation. 2009 Jan 27;119(3):362-4. No abstract available. PMID: 19171864 [PubMed - indexed for MEDLINE]Related articles

Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.

Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.

Am J Cardiol. 2009 Feb 1;103(3):369-74. Epub 2008 Oct 30.PMID: 19166691 [PubMed - indexed for MEDLINE]Related articles

Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.

Nambi V, Morrison AC, Hoogeveen RC, Coresh J, Miles S, Rhodes CE, Sharrett AR, Boerwinkle BE, Ballantyne CM.

Tex Heart Inst J. 2008;35(4):388-94.PMID: 19156230 [PubMed - indexed for MEDLINE]Related articlesFree article

National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.

NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, Pfeiffer CM, Grundy SM, Labarthe DR, Levy D, Rifai N, Wilson PW.

Clin Chem. 2009 Feb;55(2):378-84. Epub 2008 Dec 23.PMID: 19106185 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.

Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, Ni H, Boerwinkle E, Mosley T, Sharrett R, Folsom AR, Ballantyne CM.

Stroke. 2009 Feb;40(2):376-81. Epub 2008 Dec 18.PMID: 19095974 [PubMed - indexed for MEDLINE]Related articlesFree article

Platelet reactivity and response to aspirin in subjects with the metabolic syndrome.

Vaduganathan M, Alviar CL, Arikan ME, Tellez A, Guthikonda S, DeLao T, Granada JF, Kleiman NS, Ballantyne CM, Lev EI.

Am Heart J. 2008 Nov;156(5):1002.e1-1002.e7.PMID: 19061719 [PubMed - indexed for MEDLINE]Related articles

Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.

Paolini JF, Bays HE, Ballantyne CM, Davidson M, Pasternak R, Maccubbin D, Norquist JM, Lai E, Waters MG, Kuznetsova O, Sisk CM, Mitchel YB.

Cardiol Clin. 2008 Nov;26(4):547-60. Review.PMID: 19031552 [PubMed - indexed for MEDLINE]Related articles

Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment.

Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T.

Science. 2008 Nov 14;322(5904):1101-4. Erratum in: Science. 2009 Aug 21;325(5943):946. PMID: 19008446 [PubMed - indexed for MEDLINE]Related articlesFree article

Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery?

Virani SS, Nambi V, Lee VV, Elayda M, Reul RM, Wilson JM, Ballantyne CM.

Am J Cardiol. 2008 Nov 1;102(9):1235-9. Epub 2008 Aug 27.PMID: 18940299 [PubMed - indexed for MEDLINE]Related articles

Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: the Atherosclerosis Risk in Communities study.

Yan Y, North KE, Ballantyne CM, Brancati FL, Chambless LE, Franceschini N, Heiss G, Kottgen A, Pankow JS, Selvin E, West SL, Boerwinkle E.

Diabetes. 2009 Jan;58(1):285-9. Epub 2008 Oct 17.PMID: 18931037 [PubMed - indexed for MEDLINE]Related articlesFree article

Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.

Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP.

Am Heart J. 2008 Oct;156(4):719-27. Epub 2008 Jul 11.PMID: 18926153 [PubMed - indexed for MEDLINE]Related articles

Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity.

Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM.

Obesity (Silver Spring). 2008 Dec;16(12):2593-600. Epub 2008 Oct 2.PMID: 18833212 [PubMed - indexed for MEDLINE]Related articles

Association of lactate with blood pressure before and after rapid weight loss.

Crawford SO, Ambrose MS, Hoogeveen RC, Brancati FL, Ballantyne CM, Young JH.

Am J Hypertens. 2008 Dec;21(12):1337-42. Epub 2008 Sep 18.PMID: 18802433 [PubMed - indexed for MEDLINE]Related articles

The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.

Friedewald VE Jr, Ballantyne CM, Davidson MH, Guyton JR, Roberts WC.

Am J Cardiol. 2008 Sep 1;102(5):559-67. No abstract available. PMID: 18721512 [PubMed - indexed for MEDLINE]Related articles

Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.

Ballantyne CM, Raichlen JS, Cain VA.

J Am Coll Cardiol. 2008 Aug 19;52(8):626-32.PMID: 18702965 [PubMed - indexed for MEDLINE]Related articles

Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.

Davidson MH, Ballantyne CM.

Am J Cardiol. 2008 Apr 17;101(8A):1B-2B. No abstract available. PMID: 18375235 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.

Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E.

Am J Clin Nutr. 2008 Jun;87(6):1926-31.PMID: 18541586 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles.

Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, Simon DI, Plow EF.

Blood. 2008 Sep 15;112(6):2327-35. Epub 2008 May 28.PMID: 18509085 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.

Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS.

Int J Obes (Lond). 2008 May;32 Suppl 2:S21-4.PMID: 18469836 [PubMed - indexed for MEDLINE]Related articles

Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).

Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH.

Am J Cardiol. 2008 May 15;101(10):1428-36.PMID: 18471454 [PubMed - indexed for MEDLINE]Related articles

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.

Mohler ER 3rd, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A; Darapladib Investigators.

J Am Coll Cardiol. 2008 Apr 29;51(17):1632-41.PMID: 18436114 [PubMed - indexed for MEDLINE]Related articles

Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE; ASTEROID Investigators.

Circulation. 2008 May 13;117(19):2458-66. Epub 2008 Mar 31.PMID: 18378607 [PubMed - indexed for MEDLINE]Related articlesFree article

The editor's roundtable: atherosclerosis regression.

Friedewald VE, Ballantyne CM, Nissen SE, Shah PK, Roberts WC.

Am J Cardiol. 2008 Apr 1;101(7):967-74. No abstract available. PMID: 18359316 [PubMed - indexed for MEDLINE]Related articles

Developmental control of integrin expression regulates Th2 effector homing.

Lee SH, Prince JE, Rais M, Kheradmand F, Ballantyne CM, Weitz-Schmidt G, Smith CW, Corry DB.

J Immunol. 2008 Apr 1;180(7):4656-67.PMID: 18354189 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.

Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR.

Am J Cardiol. 2008 Feb 15;101(4):490-6. Epub 2007 Dec 20.PMID: 18312764 [PubMed - indexed for MEDLINE]Related articles

Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.

Paolini JF, Mitchel YB, Reyes R, Kher U, Lai E, Watson DJ, Norquist JM, Meehan AG, Bays HE, Davidson M, Ballantyne CM.

Am J Cardiol. 2008 Mar 1;101(5):625-30. Epub 2007 Dec 21.PMID: 18308010 [PubMed - indexed for MEDLINE]Related articles

Endothelial domes encapsulate adherent neutrophils and minimize increases in vascular permeability in paracellular and transcellular emigration.

Phillipson M, Kaur J, Colarusso P, Ballantyne CM, Kubes P.

PLoS One. 2008 Feb 20;3(2):e1649.PMID: 18297135 [PubMed - indexed for MEDLINE]Related articlesFree article

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.

Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM.

Am Heart J. 2008 Mar;155(3):541-6. Epub 2007 Dec 19.PMID: 18294494 [PubMed - indexed for MEDLINE]Related articles

Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.

Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E.

Am J Hypertens. 2008 May;21(5):533-8. Epub 2008 Feb 21.PMID: 18292760 [PubMed - indexed for MEDLINE]Related articlesFree article